logo

For the Inventor, By the Inventor

Providence, RI, United States of America

Epivax, Inc.


USPTO Granted Patents = 22

% Expired Patents = 45.5



Trademarks = 8

Forward Citations = 88

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal William Martin (19 out of 28 patents)

silverMedal Anne Searls De Groot (18 out of 18 patents)

bronzeMedal Daniel S Rivera (15 out of 16 patents)

4.  Daniel Hoft (2 out of 3 patents)

5.  Annie De Groot (2 out of 3 patents)

6.  Amy S Rosenberg (2 out of 2 patents)

7.  Chris Eickhoff (1 out of 1 patent)

8.  Mark C Poznansky (1 out of 32 patents)

9.  Anja Garritsen (1 out of 2 patents)

10.  Anja Scholzen (1 out of 1 patent)

11.  Leonard Jeffrey Moise (1 out of 1 patent)

12.  Timothy Alan Brauns (1 out of 5 patents)

13.  Ann Elizabeth Sluder (1 out of 1 patent)

14.  Christopher S Eickhoff (1 out of 1 patent)

15.  William D Martin (0 patent)


22 patents:

1. 12275956 - Regulatory T cell epitopes (2025-04-14),
2. 12247053 - Peptides for inducing heterosubtypic influenza T cell responses (2025-03-11),
3. 12016909 - Regulatory T cell epitopes, compositions and uses thereof (2024-06-25),
4. 11911414 - Regulatory T cell epitopes (2024-02-27),
5. 11844826 - Regulatory T cell epitopes, compositions and uses thereof (2023-12-19),
6. 11690902 - epitopes for T cell-targeted Q fever vaccines (2023-07-04),
7. 11441122 - Regulatory T cell epitopes (2022-09-13),
8. 11045532 - Regulatory T cell epitopes, compositions and uses thereof (2021-06-29),
9. 11045531 - Regulatory T cell epitopes, compositions and uses thereof (2021-06-29),
10. 11045530 - Regulatory T cell epitopes, compositions and uses thereof (2021-06-29),
11. 11045529 - Regulatory T cell epitopes, compositions and uses thereof (2021-06-29),
12. 11045528 - Regulatory T cell epitopes, compositions and uses thereof (2021-06-29),
13. 10980867 - Regulatory T cell epitopes, compositions and uses thereof (2021-04-20),
14. 10925942 - Regulatory T cell epitopes, compositions and uses thereof (2021-02-23),
15. 10925941 - Regulatory T cell epitopes, compositions and uses thereof (2021-02-23),
Company Overview
Epivax, Inc. is a biotechnology company based in Providence, Rhode Island, specializing in the development of innovative immunotherapeutics and vaccines. The organization focuses on leveraging computational biology and advanced immunology to create solutions for infectious diseases and cancer. By utilizing proprietary algorithms and platforms, Epivax aims to enhance vaccine design and optimize immune responses, contributing to the advancement of personalized medicine and public health initiatives.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Epivax, Inc. USPTO Patent Assignee Logo
22 Patents

#19 in Providence, RI

#75 in Rhode Island

#15,037 in US

#28,782 in the World

Providence, RI (US)
Providence, RI, United States of America

Epivax, Inc.

Forward Citations = 88

14 inventors:

goldMedal William Martin (19 out of 28 patents)

silverMedal Anne Searls De Groot (18 out of 18 patents)

bronzeMedal Daniel S Rivera (15 out of 16 patents)

4.  Daniel Hoft (2 out of 3 patents)

5.  Annie De Groot (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Epivax, Inc.. Retrieved from https://idiyas.com/company/epivax

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…